Condition
Lobular Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Lobular Breast Carcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Italy (2)). 1 was first registered in the last 30 days. By phase: Phase 2 (3), Phase 4 (1). The most active sponsors are Memorial Sloan Kettering Cancer Center (2), University of Wisconsin, Madison (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1New in 30 days
- 2Countries
Newest Lobular Breast Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| 18F-FES PET/MRI to find hidden disease in invasive lobular breast cancer | Phase 4 | Madison, Wisconsin | Recruiting | Nov 2, 2026 |
| Lobular Breast Cancer with Low or No Hormone Receptors: Real-World International Cohort | — | Padova | Recruiting | May 29, 2026 |
| Pre-surgery hormone therapy to lower positive margins in lobular breast cancer | Phase 2 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Mar 19, 2026 |
| Identifying biomarkers for endocrine therapy resistance in lobular breast cancer | Phase 2 | Madison, Wisconsin | Recruiting | Oct 5, 2023 |
| FES-PET/MRI to tailor treatment for Luminal A and ER-positive lobular breast cancer | Phase 2 | Milan, MI | Recruiting | Aug 8, 2023 |
| Registry for patients with metastatic lobular breast cancer | — | San Diego, California and 3 other locations | Recruiting | Jul 28, 2023 |
| Comparing two radiation therapy techniques for advanced solid tumors | — | Basking Ridge, New Jersey and 6 other locations | Recruiting | May 1, 2023 |
All recruiting trials (7)
-
18F-FES PET/MRI to find hidden disease in invasive lobular breast cancer
This study tests whether adding 18F-FES PET/MRI can reveal more disease in lobular breast cancer than standard imaging alone.
-
Lobular Breast Cancer with Low or No Hormone Receptors: Real-World International Cohort
This study tests how hormone receptor–negative/low lobular breast cancer behaves in real-world patients by collecting data from multiple centers.
-
Pre-surgery hormone therapy to lower positive margins in lobular breast cancer
This Phase 2 trial tests whether giving endocrine (hormone) therapy before breast-conserving surgery can reduce the chance of cancer at the edges of the removed tissue in postmenopausal people with ER+/HER2- invasive lobular breast cancer.
-
Identifying biomarkers for endocrine therapy resistance in lobular breast cancer
This study is trying to find markers in the blood that can help doctors understand how well patients with lobular breast cancer respond to hormone therapy.
-
FES-PET/MRI to tailor treatment for Luminal A and ER-positive lobular breast cancer
This study tests whether a combined FES-PET/MRI scan can help plan treatment for women with Luminal A or ER-positive lobular breast cancer.
-
Registry for patients with metastatic lobular breast cancer
This study is collecting information from patients with metastatic lobular breast cancer to see how they respond to treatments and understand their overall health over time.
-
Comparing two radiation therapy techniques for advanced solid tumors
This study is testing whether a new type of radiation therapy works better than the standard method for treating advanced solid tumors that have spread, to see if it can improve outcomes for patients needing palliative care.
Related topics
Quick answers
How many Lobular Breast Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.